Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on March 30, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2007.040014
© The Physiological Society 2008

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/5/538    most recent
expphysiol.2007.040014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurley, S. B
Right arrow Articles by Coffman, T. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurley, S. B
Right arrow Articles by Coffman, T. M

Received February 10, 2008
Revised February 27, 2008
Accepted after revision February 27, 2008


Genomic Physiology [220]

Gene Targeting Studies of ACE2 in Cardiovascular Physiology: Mixed Messages

Susuan B Gurley 1 Thomas M Coffman 1*

1 Duke University Medical Center

* To whom correspondence should be addressed. E-mail: tcoffman{at}duke.edu.


   Abstract
As a major regulator of blood pressure homeostasis, the renin-angiotensin system (RAS) has been the subject of extensive scientific investigation. While the RAS was first discovered more than 100 years ago, several novel components of the system have been identified just in the last decade. One of these newer members of the RAS family is ACE2. Among the approaches used to establish a physiological role for ACE2 has been the generation of ACE2-null mouse lines using homologous recombination in embryonic stem cells. In the literature, there have been at least three lines of ACE2 knockout mice generated by gene targeting by different investigative groups. Interestingly, there are significant differences in some of the reported phenotypes of these distinct lines, especially with regard to their cardiovascular physiology. In this paper, we will review the results of published experiments using these ACE2-null mouse lines, highlighting similarities and differences in these studies and summarizing their contributions to our understanding of the physiological functions of this novel member of the RAS.

Key Words: Angiotensin, Cardiovascular, Hypertension




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.